{"id":379193,"date":"2020-11-12T01:03:22","date_gmt":"2020-11-12T06:03:22","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=379193"},"modified":"2020-11-12T01:03:22","modified_gmt":"2020-11-12T06:03:22","slug":"sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\/","title":{"rendered":"Sequana Medical to present at Jefferies 2020 Virtual London Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">GHENT, Belgium, Nov.  12, 2020  (GLOBE NEWSWIRE) &#8212; <strong>Sequana Medical NV <\/strong><strong>(Euronext Brussels: SEQUA<\/strong><strong>)<\/strong>, an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, today announces that Ian Crosbie, Chief Executive Officer, will present at the Jefferies 2020 Virtual London Healthcare Conference taking place from 17 to 19 November 2020.\u00a0 \u00a0 \u00a0 \u00a0\u00a0<\/p>\n<p align=\"justify\">\n        <strong>Company presentation<\/strong><br \/>\n        <strong>with live webcast <\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">Thursday, 19 November 2020 at 11:35 am CET<\/li>\n<li>To register for the webcast, click <a href=\"https:\/\/wsw.com\/webcast\/jeff141\/sequa.br\/2372625\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">here<\/a><\/li>\n<li>The presentation and a replay of the webcast will be available on <a href=\"https:\/\/www.sequanamedical.com\/investors\/events-presentations\/\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Sequana Medical\u2019s Investors website<\/a> shortly after the event<\/li>\n<\/ul>\n<p>To request a one-on-one meeting with the Sequana Medical management team, contact us at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UON8vTcPX33XYkm_G67JwXjYcKzJZRKeXwqOI0pzcnd6482ajBWStX9E2Zeja152EYQFX7LYcCTUFa1EYOGxSqu9UCZXz89CHET-lizPV0k=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">IR@sequanamedical.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>For more information, please contact: <\/strong><br \/>\n        \n      <\/p>\n<p align=\"justify\">\n        <strong>Sequana Medical<\/strong><br \/>\n        <br \/>Lies Vanneste, Director Investor Relations<br \/>Tel: +32 (0) 498 05 35 79<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UON8vTcPX33XYkm_G67JwXjYcKzJZRKeXwqOI0pzcne5cJJd-g240X8TGsB9DvIfJ0VovsNotbeO_uri9ycnaVPqG8tlNF3Y-IziJe1ouEk=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">IR@sequanamedical.com<\/a><\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:40%;width:40%;min-width:40%;vertical-align: top\">\n            <strong>Consilium Strategic Communications<\/strong><br \/>\n            <br \/>Amber Fennell, Ashley Tapp, Melissa Gardiner<br \/>Tel: +44 203 709 5000<br \/>Email: <a href=\"mailto:sequanamedical@consilium-comms.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">sequanamedical@consilium-comms.com<\/a>\u00a0\u00a0<\/td>\n<td style=\"max-width:60%;width:60%;min-width:60%;text-align: justify;vertical-align: middle;vertical-align: top\">\n            <strong>LifeSci Advisors<\/strong><br \/>\n            <br \/>Chris Maggos<br \/>Tel: +41 79 367 6254<br \/>Email: <a href=\"mailto:chris@lifesciadvisors.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">chris@lifesciadvisors.com<\/a>\u00a0\u00a0\u00a0 <\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">\n        <strong>About Sequana Medical<\/strong><br \/>\n        <br \/>Sequana Medical is a commercial stage medical device company developing the <strong>alfa<\/strong>pump platform for the management of fluid overload in liver disease, malignant ascites and heart failure where diuretics are no longer effective. Fluid overload is a fast growing complication of advanced liver disease driven by NASH (non-alcoholic steatohepatitis) related cirrhosis and a common complication in heart failure. The U.S. market for the <strong>alfa<\/strong>pump resulting from NASH-related cirrhosis is forecast to exceed \u20ac3 billion annually within the next 10-20 years. The heart failure market for the <strong>alfa<\/strong>pump DSR (Direct Sodium Removal) is estimated to be over \u20ac5 billion annually in the U.S. and EU5 by 2026. Both indications leverage Sequana Medical&#8217;s <strong>alfa<\/strong>pump, a unique, fully implanted wireless device that automatically pumps fluid from the abdomen into the bladder, where it is naturally eliminated through urination.<\/p>\n<p align=\"justify\">In the U.S., the company&#8217;s key growth market, the <strong>alfa<\/strong>pump has been granted breakthrough device designation by the FDA. The North American pivotal study (POSEIDON) in recurrent and refractory ascites due to liver cirrhosis is currently underway, and is intended to support a commercial marketing application of the <strong>alfa<\/strong>pump in the U.S. and Canada. In Europe, the <strong>alfa<\/strong>pump is CE-marked for the management of refractory ascites due to liver cirrhosis and malignant ascites and is included in key clinical practice guidelines. Over 800 <strong>alfa<\/strong>pump systems have been implanted to date. Building on its proven <strong>alfa<\/strong>pump platform, Sequana Medical is developing the <strong>alfa<\/strong>pump DSR, a breakthrough, proprietary approach to fluid overload due to heart failure. Clinical proof-of-concept was achieved in a first-in-human single dose DSR study and further supported by strong interim safety and efficacy results from the ongoing repeated dose <strong>alfa<\/strong>pump DSR study (RED DESERT) in heart failure patients.<\/p>\n<p align=\"justify\">Sequana Medical is headquartered in Ghent, Belgium. For further information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=K5rrfd8dEvddimhLvFxvAk5gNSQsAt9jxAI4ENaQv3ZeaTpwIU1FTuaj9MbCdtYyAmMY-697-SQsvwPhRfnua7aTT6oXrom0CJUmjAuEe5Y=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.sequanamedical.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <em>Important Regulatory Disclaimers<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>\n        <em>The\u00a0<\/em><br \/>\n        <strong><br \/>\n          <em>alfa<\/em><br \/>\n        <\/strong><br \/>\n        <em>pump<sup>\u00ae<\/sup> system is not currently approved in the United States or Canada. In the United States and Canada, the\u00a0<\/em><br \/>\n        <strong><br \/>\n          <em>alfa<\/em><br \/>\n        <\/strong><br \/>\n        <em>pump<sup>\u00ae<\/sup> system is currently under clinical investigation (POSEIDON Study) and is being studied in adult patients with refractory or recurrent ascites due to cirrhosis. For more information regarding the POSEIDON clinical study see\u00a0<\/em><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=w2nYMMeOQjGsXV0cs7OYAampT-HM7NZkrQhnhvxeFuP3_Mtu_0dPp2js4A2FkIgIIJFr3Oc49a8S_KlMDWek-TXLkQkDRbxh-r7eiqWb4ts=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/>\n          <em>www.poseidonstudy.com<\/em><br \/>\n        <\/a><br \/>\n        <em>. The DSR therapy is still in development and it should be noted that any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed. The DSR therapy is not currently approved for clinical research in the United States or Canada. There is no link between the DSR therapy and ongoing investigations with the\u00a0<\/em><br \/>\n        <strong><br \/>\n          <em>alfa<\/em><br \/>\n        <\/strong><br \/>\n        <em>pump<sup>\u00ae<\/sup> system in Europe.<\/em>\n      <\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <em>Forward-looking statements<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>\n        <em>This press release may contain predictions, estimates or other information that might be considered forward-looking statements. Such forward-looking statements are not guarantees of future performance. These forward-looking statements represent the current judgment of Sequana Medical on what the future holds, and are subject to risks and uncertainties that could cause actual results to differ materially. Sequana Medical expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release, except if specifically required to do so by law or regulation. You should not place undue reliance on forward-looking statements, which reflect the opinions of Sequana Medical only as of the date of this press release.<\/em>\n      <\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDE4MCMzODIyMDE3IzUwMDA2NjM3Mw==\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>GHENT, Belgium, Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, today announces that Ian Crosbie, Chief Executive Officer, will present at the Jefferies 2020 Virtual London Healthcare Conference taking place from 17 to 19 November 2020.\u00a0 \u00a0 \u00a0 \u00a0\u00a0 Company presentation with live webcast Thursday, 19 November 2020 at 11:35 am CET To register for the webcast, click here The presentation and a replay of the webcast will be available on Sequana Medical\u2019s Investors website shortly after the event To request a one-on-one meeting with the Sequana Medical management team, contact us at IR@sequanamedical.com. For more information, please contact: Sequana &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Sequana Medical to present at Jefferies 2020 Virtual London Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-379193","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sequana Medical to present at Jefferies 2020 Virtual London Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sequana Medical to present at Jefferies 2020 Virtual London Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"GHENT, Belgium, Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, today announces that Ian Crosbie, Chief Executive Officer, will present at the Jefferies 2020 Virtual London Healthcare Conference taking place from 17 to 19 November 2020.\u00a0 \u00a0 \u00a0 \u00a0\u00a0 Company presentation with live webcast Thursday, 19 November 2020 at 11:35 am CET To register for the webcast, click here The presentation and a replay of the webcast will be available on Sequana Medical\u2019s Investors website shortly after the event To request a one-on-one meeting with the Sequana Medical management team, contact us at IR@sequanamedical.com. For more information, please contact: Sequana &hellip; Continue reading &quot;Sequana Medical to present at Jefferies 2020 Virtual London Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-12T06:03:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDE4MCMzODIyMDE3IzUwMDA2NjM3Mw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Sequana Medical to present at Jefferies 2020 Virtual London Healthcare Conference\",\"datePublished\":\"2020-11-12T06:03:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\\\/\"},\"wordCount\":696,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NDE4MCMzODIyMDE3IzUwMDA2NjM3Mw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\\\/\",\"name\":\"Sequana Medical to present at Jefferies 2020 Virtual London Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NDE4MCMzODIyMDE3IzUwMDA2NjM3Mw==\",\"datePublished\":\"2020-11-12T06:03:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NDE4MCMzODIyMDE3IzUwMDA2NjM3Mw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NDE4MCMzODIyMDE3IzUwMDA2NjM3Mw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sequana Medical to present at Jefferies 2020 Virtual London Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sequana Medical to present at Jefferies 2020 Virtual London Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Sequana Medical to present at Jefferies 2020 Virtual London Healthcare Conference - Market Newsdesk","og_description":"GHENT, Belgium, Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, today announces that Ian Crosbie, Chief Executive Officer, will present at the Jefferies 2020 Virtual London Healthcare Conference taking place from 17 to 19 November 2020.\u00a0 \u00a0 \u00a0 \u00a0\u00a0 Company presentation with live webcast Thursday, 19 November 2020 at 11:35 am CET To register for the webcast, click here The presentation and a replay of the webcast will be available on Sequana Medical\u2019s Investors website shortly after the event To request a one-on-one meeting with the Sequana Medical management team, contact us at IR@sequanamedical.com. For more information, please contact: Sequana &hellip; Continue reading \"Sequana Medical to present at Jefferies 2020 Virtual London Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-12T06:03:22+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDE4MCMzODIyMDE3IzUwMDA2NjM3Mw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Sequana Medical to present at Jefferies 2020 Virtual London Healthcare Conference","datePublished":"2020-11-12T06:03:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\/"},"wordCount":696,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDE4MCMzODIyMDE3IzUwMDA2NjM3Mw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\/","name":"Sequana Medical to present at Jefferies 2020 Virtual London Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDE4MCMzODIyMDE3IzUwMDA2NjM3Mw==","datePublished":"2020-11-12T06:03:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDE4MCMzODIyMDE3IzUwMDA2NjM3Mw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDE4MCMzODIyMDE3IzUwMDA2NjM3Mw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sequana-medical-to-present-at-jefferies-2020-virtual-london-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Sequana Medical to present at Jefferies 2020 Virtual London Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/379193","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=379193"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/379193\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=379193"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=379193"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=379193"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}